Daicel (9DC) Stock Overview
Engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
9DC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥7.65 |
| 52 Week High | JP¥9.00 |
| 52 Week Low | JP¥6.05 |
| Beta | 0.55 |
| 1 Month Change | -4.38% |
| 3 Month Change | 10.87% |
| 1 Year Change | -3.77% |
| 3 Year Change | -7.27% |
| 5 Year Change | 9.29% |
| Change since IPO | -33.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9DC | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -5.6% | -1.1% | -2.1% |
| 1Y | -3.8% | 15.9% | 3.6% |
Return vs Industry: 9DC underperformed the German Chemicals industry which returned 15.5% over the past year.
Return vs Market: 9DC underperformed the German Market which returned 4.6% over the past year.
Price Volatility
| 9DC volatility | |
|---|---|
| 9DC Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 4.4% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in DE Market | 12.6% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 9DC has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 9DC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,034 | Yasuhiro Sakaki | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services. It also provides performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photoresists, optical lenses, and caprolactone derivatives; functional films and materials used in smartphones, PCs, TVs, and in-vehicle displays, polymers and solvents used in the semiconductor manufacturing process; and lenses used in VR, smartphones and various sensors.
Daicel Corporation Fundamentals Summary
| 9DC fundamental statistics | |
|---|---|
| Market cap | €1.99b |
| Earnings (TTM) | €55.35m |
| Revenue (TTM) | €3.31b |
Is 9DC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9DC income statement (TTM) | |
|---|---|
| Revenue | JP¥592.74b |
| Cost of Revenue | JP¥444.59b |
| Gross Profit | JP¥148.15b |
| Other Expenses | JP¥138.23b |
| Earnings | JP¥9.92b |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Nov 05, 2026
| Earnings per share (EPS) | 38.84 |
| Gross Margin | 24.99% |
| Net Profit Margin | 1.67% |
| Debt/Equity Ratio | 81.1% |
How did 9DC perform over the long term?
See historical performance and comparisonDividends
Does 9DC pay a reliable dividends?
See 9DC dividend history and benchmarks| Daicel dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2026 |
| Dividend Pay Date | Dec 02 2026 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 82 days |
Does 9DC pay a reliable dividends?
See 9DC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/10 05:29 |
| End of Day Share Price | 2026/09/10 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daicel Corporation is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mikiya Yamada | Barclays |
| Takashi Enomoto | BofA Global Research |
| Sze Tee | CGS International |